Triptolide reverses the Taxol resistance of lung adenocarcinoma by inhibiting the NF-κB signaling pathway and the expression of NF-κB-regulated drug-resistant genes

Paclitaxel (or Taxol(®)) is a first-line chemotherapeutic drug for the treatment of non-small cell lung cancer; however, resistance to the drug is an important factor, which influences the outcome of chemotherapy. The present study aimed to investigate the role of triptolide (TPL) in reversing Taxol...

Descripción completa

Detalles Bibliográficos
Autores principales: JIANG, NING, DONG, XIAO-PENG, ZHANG, SUO-LIN, YOU, QING-YONG, JIANG, XING-TAO, ZHAO, XIAO-GANG
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2016
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4686042/
https://www.ncbi.nlm.nih.gov/pubmed/26531258
http://dx.doi.org/10.3892/mmr.2015.4493

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4686042/
https://www.ncbi.nlm.nih.gov/pubmed/26531258
http://dx.doi.org/10.3892/mmr.2015.4493

Ejemplares similares